849.55
-1.76%
Ashika Research
Natco Pharma Ltd. (NPL) is a midsized pharmaceutical company with a presence across the pharma value chain. It owns eight manufacturing facilities including six formulations facilities and two API facilities. The company also has a US retail business. Natco is a leading domestic player in the oncology space. NPL's product pipeline consists of drugs,...
Number of FII/FPI investors decreased from 317 to 235 in Sep 2025 qtr
More from Natco Pharma Ltd.
Recommended